The GLP is committed to full transparency. Download and review our Annual Report.

The GLP is committed to full transparency. Download and review our Annual Report.

FDA approves experimental stem cell therapy to help deaf ear repair itself

The Food and Drug Administration (FDA) has recently approved a groundbreaking trial by the University of Texas Medical School at Houston to evaluate the safety of using a child’s own cord blood stem cells to regenerate damaged cells in the inner ear and potentially restore the child’s hearing. Just as antibiotics changed the treatment of infections, stem cells may revolutionize the future of nervous system repair.

View the original article here: FDA approves experimental stem cell therapy to help deaf ear repair itself

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend